Article Menu

Export Article

More by Authors Links

Article Data

  • Views 473
  • Dowloads 137

Case Reports

Open Access

Incidental tubal endometrioid adenocarcinoma – case report

  • J. Varga1,*,
  • P. Švajdler2
  • R. Dankovčík1
  • M. Rabajdová3
  • F. Gmitter2
  • A. Ostró1

1Department of Gynaecology and Obstetrics, Faculty of Medicine, P.J. Šafarik University and L. Pasteur University Hospital, Košice, Slovakia

2Department of Pathology, L. Pasteur University Hospital, Košice, Slovakia

3Department of Chemistry, Biochemistry, Medical Biochemistry and LABMED, Faculty of Medicine, P. J. Šafarik University, Košice, Slovakia

DOI: 10.12892/ejgo3226.2016 Vol.37,Issue 6,December 2016 pp.873-875

Published: 10 December 2016

*Corresponding Author(s): J. Varga E-mail: janko.varga@gmail.com

PDF (98.84 kB)

Abstract

The fallopian tubes represent a highly important structure for ovarian carcinogenesis. They provide the passage of eutopic endometrium from the uterus, as well as metastatic cells from the ovaries. A direct source of tumor cells for ovarian cancer was also recently confirmed in the fallopian tubes. The authors present a case report of an incidental tubal endometrioid carcinoma with the coexistence of adenomyosis.


Keywords

Fallopian tubes; Endometrioid carcinoma; Adenomyosis.

Cite and Share

J. Varga,P. Švajdler,R. Dankovčík,M. Rabajdová,F. Gmitter,A. Ostró. Incidental tubal endometrioid adenocarcinoma – case report. European Journal of Gynaecological Oncology. 2016. 37(6);873-875.

URL:

https://www.ejgo.net/articles/10.12892/ejgo3226.2016

References

[1] Kulac I., Usubutun A.: “Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques?” J. Gynecol. Oncol., 2013, 24, 114.

[2] Koshiyama M., Matsumura N., Konishi I.: “Recent concepts of ovarian carcinogenesis: type I and type II”. Biomed. Res. Int., 2014, 2014, 934261.

[3] Maeda D., Shih leM.: “Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms”. Adv. Anat. Pathol., 2013, 20, 45.

[4] Kuhn E., Kurman R.J., Shih I.M.: “Ovarian cancer is an important disease: fact or fiction?” Curr. Obstet. Gynecol. Rep., 2012, 1, 1.

[5] Kurman R.J., Vang R., Junge J., Hannibal C.G., Kjaer S.K., Shih IeM.: “Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants,and endosalpingiosis”. Am. J. Surg. Pathol., 2011, 3, 1605.

[6] Králíčková M., Vetvicka V.: “Endometriosis and ovarian cancer”. World J. Clin. Oncol., 2014, 5, 800.

[7] Piek J.M.J., Verheijen H.M., Kenemans P., Massuger L.F., Bulten H., vanDiest P.J.: “BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis”. Gynecol. Oncol., 2003, 90, 491.

[8] Folkins A.K., Jarboe E.A., Saleemuddin A., Lee Y., Callahan M.J., Drapkin R., et al.: “A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations”. Gynecol. Oncol., 2008, 109, 168.

[9] Przybycin C.G., Kurman R.J., Ronnett B.M., Shih IeM., Vang R.: “Are all pelvic (nonuterine) serous carcinomas of tubal origin?” Am. J. Surg. Pathol., 2010, 34, 1407.

[10] Yamaguchi K., Mandai M., Toyokuni S., Hamanishi J., Higuchi T., Takakura K., Fujii S.: “Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress”. Clin. Cancer Res., 2008, 14, 32.

[11] Wei J.J., William J., Bulun S.: “Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects”. Int. J. Gynecol.Pathol., 2011, 30, 553. [12] Taga S., Sawada M., Nagai A., Yamamoto D., Hayase R.: “A case of endometrioid adenocarcinoma arising from adenomyosis”. Case Rep. Obstet. Gynecol., 2014, 2014, 569295.

[13] Kucera E., Hejda V., Dankovcik R., Valha P., Dudas M., Feyereisl J.: “Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma”. Eur. J. Gynaecol. Oncol., 2011, 32, 182.

[14] Culton L.K., Deavers M.T., Silva E.G., Liu J., Malpica A.: “Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases”. Am. J. Surg. Pathol., 2006, 30, 844.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top